Huadong Medicine has obtained approvals for three new products at the start of the year, which is nearly half of last year's total.|Quick read announcement.

1. Huadong Medicine announced today that three products have received approval for market entry, while a total of seven products were approved last year; 2. Among them, a hyaluronic acid product for medical aesthetics and a chemical drug for the treatment of ovarian cancer received domestic approval, while a medical instrument for assessing kidney function received approval in the USA; 3. Huadong Medicine believes that the approvals will not have a significant impact on the company's current financial situation and operational results.

cls.cnJan 20 10:31 ET

The recovery of Semiconductors could not withstand the erosion of costs, Hunan Kaimeite Gases' losses widened last year | Interpretations

① Hunan Kaimeite Gases expects to incur a net income loss of 43.8 million yuan to 54 million yuan in 2024; ② The company stated that the main reasons for the decline in performance are: first, the prices of rare gas related products decreased; second, the termination of the restrictive stocks incentive plan implemented in 2022, which will be included as corresponding costs and expenses in 2024.

cls.cnJan 20 10:17 ET

Investing over 0.4 billion, Qiming Venture Capital enters Zhengzhou Tiamaes Technology. Is the "shell buying craze" restarting?

① After this Trade is completed, the controlling Shareholder of Zhengzhou Tiamaes Technology will change to Qiming Fund, and the actual controller of the listed company will change to Kuang Ziping. The latter is the founding managing partner of Qiming Venture Capital. ② People from the Venture Capital Institutions indicate that Qiming Venture Capital's entry into Zhengzhou Tiamaes Technology this time may ultimately aim to realize investment exit by injecting its Assets into the listed company. ③ A wave of "shell buying" by Venture Capital Institutions occurred in the A-share market in 2019.

cls.cnJan 7 04:58 ET

Zhengzhou Tiamaes Technology's "change of ownership" plan has emerged: Trade sets "different pricing for the same shares" with well-known VC participating in the integration.

① The well-known VC Qiming Venture Capital founder Kuang Ziping is about to become the actual controller of Zhengzhou Tiamaes Technology; ② This Trade adopts differentiated pricing, and industry insiders indicate that differentiated pricing helps provide more negotiation space, which can facilitate the acquisition and achieve a fair Trade.

cls.cnJan 7 02:46 ET

Policy stimulus for 3C and home appliance demand release. Will the multiplier effect of the "trade-in" policy continue in 2025? | Year-end review.

In 2024, the implementation of the "national subsidy" policy for the exchange of old for new will effectively stimulate the demand for home appliances and Consumer Electronics. Market analysis suggests that related subsidies for the exchange of old for new are expected to continue next year, with mobile phones and more home improvement categories likely included, while the future policy-driven effects still remain to be observed.

cls.cnDec 29, 2024 10:17 ET

Taking profits by selling shares? In the past two months, a total of 12 A-share listed companies announced the sale of Stocks, with 60 billion retail leader Yonghui Superstores completely liquidating its holdings in Zhongbai Holdings Group.

According to incomplete Statistics, as of the time of publication, a total of 12 A-share listed companies have announced their plans or progress for selling Stocks or Assets in November (attached table). Yonghui Superstores announced a full liquidation of Zhongbai Holdings Group; Bingshan Refrigeration & Heat Transfer Technologies obtained an investment income of 33.24 million yuan from selling its shares in GTJA.

cls.cnDec 29, 2024 01:16 ET